AccueilABUS • NASDAQ
add
Tekmira Pharmaceuticals
Dernière clôture
4,26 $
Plage sur l'année
2,71 $ - 5,10 $
Capitalisation boursière
819,30 M USD
Volume moyen
2,67 M
Ratio cours/bénéfices
-
Rendement (dividendes)
-
Place boursière principale
NASDAQ
Actualités des marchés
Zonebourse Suisse
il y a 32 minutes
S&P 500: Début de semaine dans le vert avant les banques centrales
0,00 %
À propos
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Date de fondation
2007
Siège social
Site Web
Employés
44
